https://cellpointweb.com/ - Cell>Point L.L.C. privately held with offices in Colorado and Texas is a late stage Phase 3 biotech company whose principal disease focus is cancer, cardiovascular, neuroendocrine, diabetes and ischemia. The company is developing new products and technologies for innovative molecular theragnostic approaches in these diseases. Since its founding, Cell>Point has in-licensed five technology platforms from The University of Texas M.D. Anderson Cancer Center (M.D. Anderson). Call 303-689-9693.
